Powered by Blogger.
Showing posts with label Eli Lilly. Show all posts
Showing posts with label Eli Lilly. Show all posts

'Tis the Season for Legal Settlements: GlaxoSmithKline, Eli Lilly, Orthofix, Sanofi all Settle

thumbnail Reports of legal settlements by big health care organizations tend to dribble out towards the end of the year, maybe in a rush to finalize t...

"I'm Not Here to Sell Drugs" - Then Why Use Company Provided "Correct" Slides?

thumbnail In October, 2010, we discussed a series of reports by Pro Publica and multiple other respected news organizations about payments by seven p...

Eli Lilly CEO on “America’s Growing Innovation Gap”

thumbnail In “ America’s Growing Innovation Gap ”, WSJ, July 9, 2010, Eli Lilly CEO John C. Lechleiter, Ph.D. writes that: “…the most important...

Leaders of Discredited Financial Rating Agencies as Leaders of Health Care

thumbnail This is the latest in our informal series on the cross-linkages between the thinking and leadership that lead to the global financial collap...

Quintiles to More Heavily Directly Invest in the Drugs Which it Evaluates - But Not to Worry, Says an Expert?

thumbnail The Associated Press just reported on the latest trend in commercially sponsored clinical research, direct investment by contract research o...